Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/xt8hP-87Xq4/256544.php
Wednesday, 20 February 2013
Topical Treatment Of Dry Eye Disease
Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the first rationally-designed topically administered IL-1 protein for the treatment of ocular diseases...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment